CN101670054A - Chinese medicinal material with multiple efficacies - Google Patents
Chinese medicinal material with multiple efficacies Download PDFInfo
- Publication number
- CN101670054A CN101670054A CN200910192644A CN200910192644A CN101670054A CN 101670054 A CN101670054 A CN 101670054A CN 200910192644 A CN200910192644 A CN 200910192644A CN 200910192644 A CN200910192644 A CN 200910192644A CN 101670054 A CN101670054 A CN 101670054A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- chinese medicinal
- herba
- medicinal material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal material with multiple efficacies; the Chinese medicinal material is composed of multiple Chinese medicinal ingredients, and the Chinese medicinal materialwith multiple efficacies, which can defer aging, enhance immunity, can protect liver and nourish kidney, improve intestines and stomach, can detoxify and clear toxins and improve sleeping quality; meanwhile, the Chinese medicinal material has effect of Chinese medicinal material, rational price, easy-obtaining raw material and simple manufacturing process, and is suitable for people with all age groups.
Description
Technical field
The invention belongs to technical field of Chinese medicines, more specifically relate to a kind of multiple efficacies Chinese crude drug that has, especially for the Chinese medicine preparation of slow down aging.
Background technology
Theory of Chinese medical science is thought the various functions of human body after the middle age, along with aging phenomenon can appear in the increase at age, is embodied in various physiological functions and goes down, weak, insomnia, forgetful, phenomenons such as constipation, but can come restore funcitons to delay its aging by the adjusting that improves its Physiological Psychology situation or medicine.
Along with improving constantly of people's living standard, medical and health conditions are perfect day by day, people more and more pay attention to good health and a long life, on various health care medicines constantly the flooding market like the mushrooms after rain, also can be found everywhere for the defying age medicine that human body was suitable for, these medicines are very different, and cost an arm and a leg, and some health care medicines may also have side effect.
Summary of the invention
The objective of the invention is to overcome the weak point that prior art exists, a kind of delaying sanility that has is provided, enhancing immunity, but hepatoprotective, support kidney, improve the intestines and stomach, eliminating toxin and beautifying the skin, cleaning toxin, improve the Chinese crude drug of the multiple efficacies of sleep quality.
For achieving the above object, the present invention has taked following technical scheme:
A kind of have a multiple efficacies Chinese crude drug, is made up of following material composition: Radix Ginseng 25g, Radix Bupleuri 40g, Gypsum Fibrosum 25g, Radix Glycyrrhizae 20g, Fructus Lycii 30g, Radix Codonopsis 30g, Folium Nelumbinis 30g, than stilbene 25g, Rhizoma Polygonati Odorati 25g, Herba Artemisiae Scopariae 25g, Radix Dipsaci 25g, Pericarpium Citri Reticulatae 25g, Radix Dipsaci 21g, Ramulus Cinnamomi 20g, jujube pulp 18g, Rhizoma Chuanxiong 20g, Rhizoma Pinelliae 25g, Radix Rehmanniae Preparata 20g, white peony root 20g, Cortex Cinnamomi 18g, Rhizoma Atractylodis 30g, Radix Angelicae Dahuricae 18g, BAIFU 20g, Rhizomadioscoreae 20g, Radix Ophiopogonis 20g, Folium Bambusae 20g, Cortex Magnoliae Officinalis 20g, Flos Chrysanthemi 18g, Rhizoma Smilacis Glabrae 18g, Fructus Forsythiae 18g, Cortex Eucommiae 25g, Caulis Akebiae 15g, Bulbus Fritillariae Cirrhosae 15g, Herba Cistanches 25g, Radix Scrophulariae 30g, Radix Platycodonis 30g Rhizoma Cimicifugae 30g, Herba Asari 25g, Radix Peucedani 25g, Radix Angelicae Pubescentis 25g, Radix Salviae Miltiorrhizae 35g, Herba Ephedrae 15g Herba Epimedii 18g, Spica Prunellae 20g.
More than in 44 kinds of materials, when the component content of Radix Ginseng, Radix Bupleuri, Gypsum Fibrosum satisfied above dosage, the dosage of other each component can suitably reduce and not limit above gram number.
The manufacture method of Chinese crude drug of the present invention is also very simple, is specially: assort medical material by component, add decocting and endure, boil Ligularia nelumbifolia(Bur. et Franch.) Hand.-Mazz. with five bowls of water, merge medicinal liquid after also can boiling three times, took secondary on the 1st.Can be made into oral liquid or capsule.
Compared with prior art, the present invention has following beneficial effect:
1. the present invention has delaying sanility, enhancing immunity, but hepatoprotective, support kidney, improve the intestines and stomach, eliminating toxin and beautifying the skin, cleaning toxin, improve the multiple efficacies of sleep quality.
2. the present invention has no side effect, and raw material is easy to get, and processing technology is simple, is easy to promote, and price conforms with human nature, and the people who is fit to all age group uses.
The specific embodiment
Below come by specific embodiment that the invention will be further described, but the present invention's scope required for protection is not limited to the scope that embodiment is described.
A kind of have a multiple efficacies Chinese crude drug, is made up of following material composition: Radix Ginseng 25g, Radix Bupleuri 40g, Gypsum Fibrosum 25g, Radix Glycyrrhizae 20g, Fructus Lycii 30g, Radix Codonopsis 30g, Folium Nelumbinis 30g, than stilbene 25g, Rhizoma Polygonati Odorati 25g, Herba Artemisiae Scopariae 25g, Radix Dipsaci 25g, Pericarpium Citri Reticulatae 25g, Radix Dipsaci 21g, Ramulus Cinnamomi 20g, jujube pulp 18g, Rhizoma Chuanxiong 20g, Rhizoma Pinelliae 25g, Radix Rehmanniae Preparata 20g, white peony root 20g, Cortex Cinnamomi 18g, Rhizoma Atractylodis 30g, Radix Angelicae Dahuricae 18g, BAIFU 20g, Rhizomadioscoreae 20g, Radix Ophiopogonis 20g, Folium Bambusae 20g, Cortex Magnoliae Officinalis 20g, Flos Chrysanthemi 18g, Rhizoma Smilacis Glabrae 18g, Fructus Forsythiae 18g, Cortex Eucommiae 25g, Caulis Akebiae 15g, Bulbus Fritillariae Cirrhosae 15g, Herba Cistanches 25g, Radix Scrophulariae 30g, Radix Platycodonis 30g Rhizoma Cimicifugae 30g, Herba Asari 25g, Radix Peucedani 25g, Radix Angelicae Pubescentis 25g, Radix Salviae Miltiorrhizae 35g, Herba Ephedrae 15g Herba Epimedii 18g, Spica Prunellae 20g.
The manufacture method of Chinese crude drug of the present invention also is specially: assort medical material by component, add decocting and endure, boil Ligularia nelumbifolia(Bur. et Franch.) Hand.-Mazz. with five bowls of water, merge medicinal liquid after also can boiling three times, took secondary on the 1st.Can be made into oral liquid or capsule.
Claims (1)
1. Chinese crude drug with multiple efficacies is characterized in that: be made up of following 44 kinds of material compositions:
Radix Ginseng 25g, Radix Bupleuri 40g, Gypsum Fibrosum 25g, Radix Glycyrrhizae 20g, Fructus Lycii 30g, Radix Codonopsis 30g, Folium Nelumbinis 30g, than stilbene 25g, Rhizoma Polygonati Odorati 25g, Herba Artemisiae Scopariae 25g, Radix Dipsaci 25g, Pericarpium Citri Reticulatae 25g, Radix Dipsaci 21g, Ramulus Cinnamomi 20g, jujube pulp 18g, Rhizoma Chuanxiong 20g, Rhizoma Pinelliae 25g, Radix Rehmanniae Preparata 20g, white peony root 20g, Cortex Cinnamomi 18g, Rhizoma Atractylodis 30g, Radix Angelicae Dahuricae 18g, BAIFU 20g, Rhizomadioscoreae 20g, Radix Ophiopogonis 20g, Folium Bambusae 20g, Cortex Magnoliae Officinalis 20g, Flos Chrysanthemi 18g, Rhizoma Smilacis Glabrae 18g, Fructus Forsythiae 18g, Cortex Eucommiae 25g, Caulis Akebiae 15g, Bulbus Fritillariae Cirrhosae 15g, Herba Cistanches 25g, Radix Scrophulariae 30g, Radix Platycodonis 30g Rhizoma Cimicifugae 30g, Herba Asari 25g, Radix Peucedani 25g, Radix Angelicae Pubescentis 25g, Radix Salviae Miltiorrhizae 35g, Herba Ephedrae 15g Herba Epimedii 18g, Spica Prunellae 20g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910192644A CN101670054A (en) | 2009-09-24 | 2009-09-24 | Chinese medicinal material with multiple efficacies |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910192644A CN101670054A (en) | 2009-09-24 | 2009-09-24 | Chinese medicinal material with multiple efficacies |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101670054A true CN101670054A (en) | 2010-03-17 |
Family
ID=42017610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910192644A Pending CN101670054A (en) | 2009-09-24 | 2009-09-24 | Chinese medicinal material with multiple efficacies |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101670054A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104719534A (en) * | 2015-03-18 | 2015-06-24 | 苏州市天灵中药饮片有限公司 | Anti-aging tea bag and preparation method thereof |
-
2009
- 2009-09-24 CN CN200910192644A patent/CN101670054A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104719534A (en) * | 2015-03-18 | 2015-06-24 | 苏州市天灵中药饮片有限公司 | Anti-aging tea bag and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1951481A (en) | Medicament for treating cerebral thrombosis | |
CN1799620A (en) | Healthcare wine and its preparation method | |
CN102389554B (en) | Chinese medicinal formula capable of invigorating kidney yang and tonifying kidney yin as well as its product | |
CN103611082A (en) | Weight-reducing traditional Chinese medicine composition | |
CN103341133A (en) | Traditional Chinese medicine composition for treating fatty liver and preparation method thereof | |
CN101579493A (en) | Donkey-hide gelatin paste of traditional Chinese medicine | |
CN102309601A (en) | Traditional Chinese medicine (TCM) prescription for treating chloasma | |
CN1186687A (en) | Cancer preventing curing medicine series and its preparation | |
CN104547623A (en) | Traditional Chinese medicine composition for reducing fats | |
CN1408383A (en) | Pure traditional Chinese medicine preparation for curing gastroinstestinal cancer and preparing method | |
CN103550674A (en) | Blood stasis removing and blood circulation invigorating soup | |
CN101670054A (en) | Chinese medicinal material with multiple efficacies | |
CN103071079B (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
CN103272059B (en) | Traditional Chinese medicinal decoction for treating pyretic toothache | |
CN102688427A (en) | Chinese medicinal composition for treating pneumonia and preparation method thereof | |
CN101757533A (en) | Traditional Chinese medicine preparation for treating seborrheic alopecia | |
CN102309584A (en) | Traditional Chinese medicine (TCM) prescription for treating postpartum hypogalactia | |
CN103768520A (en) | Lipomata nursing medicine and preparation method thereof | |
CN100423769C (en) | Chinese medicine for treating coronary heart disease | |
CN102671042A (en) | Traditional Chinese medicinal composition for treating acne and preparation method thereof | |
CN103800859A (en) | Traditional Chinese medicinal composition for treating stomach cold | |
CN103212024A (en) | Chinese medicinal formula for treating dysmenorrhea | |
CN101530479B (en) | Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy | |
CN1382486A (en) | Fengshitongluo wan for treating rheumatism | |
CN101264186A (en) | Forming method of Chinese medicine formula for preventing and controlling dizziness and its preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Open date: 20100317 |